Six commercially available devices were tested to determine the alveolar oxygen concentration that is achieved and the volume of rebreathing that can occur in conditions simulating clinical -use. All were tested at zero oxygen flow, since failure and interruption of the oxygen supply to such devices can occur in clinical use. In patients whose cardiorespiratory reserve is exhausted, any increase in dead space will be detrimental; for such patients devices should be selected which cannot cause rebreathing under any circumstances. Three of the devices tested could cause appreciable rebreathing, i.e., Oxyaire (B.L.B. pattern), Pneumask, and the M.C. mask. Claims made for the Pneumask and the M.C. mask were not substantiated in this study. With administration by nasal catheter changes in alveolar oxygen concentrations were found to be dependent on the percentage of mouth breathing by the subject. The Ventimask produced a consistent elevation of the alveolar oxygen percentage and did not cause any increase in the dead space.
The administration of oxygen is a recognized method of treatment in a variety of clinical conditions. The authors formed the impression that an undesirable amount of rebreathing with some types of oxygen mask was possible in practice. The present study was undertaken to permit quantitative investigations of the volume of rebreathing as well as of the alveolar oxygen percentage obtained with a variety of devices.
have expressed widely varying opinions on this topic (Catterall and Snow, 1960; Catterall, 1960; and Campbell, 1960) . The method described by Cotes (1956) is not applicable to devices without rebreathing bags.
Other papers have used oxygen saturation estimated by oximetry (Ball, 1963) and mechanical models (Flenley, Hutchison, and Donald, 1963) to estimate the efficiency of equipment in delivering oxygen.
PREVIOUS STUDIES METHOD
There has been a wide variation in the methods used for testing oxygen therapy equipment; Kory, Bergmann, Sweet, and Smith (1962) gave an extensive bibliography and concluded that alveolar sampling is the most reliable index of performance.
In their results they gave values for alveolar Pco2 but commented that ventilation would be adjusted to overcome the effects of rebreathing in studies similar to theirs using normal subjects; ventilation was not measured. An earlier paper by Cotes (1956) estimated the increase in ventilation using oxygen masks fitted with reservoir bags. A valve on the reservoir could be used to prevent rebreathing. As far as we know, this is the only study which has attempted to measure the increase in effective dead space. Other authors A stethograph, made from a modified pneumatic body splint' (Fig. 1) , was arranged to drive a potentiometric recorder visible to the subject; the system was calibrated against a Parkinson Cowan Dry Gas Meter (C.D.I.). The subject maintained a constant tidal volume by observing the potentiometric recorder, previously calibrated at 500 and 1,000 ml. where VD = dead space volume (ml.); VE = minute ventilation (ml.); FA C02=fraction CO2 in alveolar gas; f =respiratory rate per minute. The subject's dead space and CO2 production per minute were calculated from independent measurements. Subtraction of the subject's dead space from the total dead space when using a mask will give the effective dead space of the mask under test. Determinations were made at zero flow and with oxygen flows of 1, 2, 4, and 8 litres per minute, time being allowed before each estimation to allow equilibration to occur.
RESULTS
Six devices were tested by this method (Fig. 2) .
The increase in ventilation with the Pneumask compensates for the increase in effective dead space, to maintain an end tidal Pco2 within normal range (Fig. 3) M.C. mask It has been claimed (Catterall, 1960) that the M.C. mask has no dead space, due to a 'continuous and organized movement of the gases inside the mask'. This claim was not substantiated in our study. The Positional changes did not produce significant changes. Our results agree with those of Campbell and Gebbie (1966) . Unfortunately the mask is manufactured in opaque plastic and the patient's face is partially obscured. In our opinion, this type of mask is the only one that we tested which is suitable for controlled oxygen therapy. Separate Ventimasks to deliver 24%, 28%, and 35% inspired oxygen are available.
Safety Pneumask This is probably the type of device for oxygen therapy most commonly used in the United Kingdom. The claim that if the oxygen supply fails the cushion deflates and the mask falls off was not substantiated. An elastic band is provided which holds the mask securely in place. In our opinion, the presence of a large dead space if the oxygen supply fails makes this device potentially dangerous.
M.C. mask The claim that the design of the mask prevents the formation of any dead space was not confirmed in this study. With zero flow the increase in effective dead space is over 100 ml.
At the recommended flow of 2 1. /min. it would still be significant in a patient with impaired cardiopulmonary reserve. We could discover no specific claims for the other three devices tested. The Oxyaire mask is capable of giving high alveolar oxygen levels and would be useful when a high oxygen level is required. A high fresh gas flow, of at least 8 1./min., will be needed to achieve this. In view of the large increase in effective dead space if the oxygen fails it should only be used under supervision. At lower oxygen flows we agree with the remark made by Cotes (1956 ) that this type of mask 'should be reserved for conditions in which some inhalation of CO2 is also desirable'. The two methods of giving nasal oxygen tested did not retain CO2 and there could be no increase in the effective dead space. There was a marked difference in the alveolar oxygen, depending on the degree of mouth and nose breathing.
CONCLUSION
The results obtained in this study confirmed the impression that some pieces of equipment used to administer oxygen therapy could cause rebreathing if the oxygen flow failed or was reduced. Hyperventilation will compensate for the rebreathing in a normal subject even with the worst device tested. However, patients who require oxygen therapy may not have a cardiopulmonary reserve to compensate for any increase in effective dead space. Post-operative (anaesthetic) hypoxaemia can be corrected by an inspired mixture of 30% oxygen (Nunn and Payne, 1962) . This can be achieved by five of the devices tested at an oxygen flow of 2 litres/minute. (The Ventimask tested was designed to give 24% inspired oxygen.) The nasal catheters could not be relied on, as patients may mouth breathe. It is unfortunate that all the other devices tested had appreciable dead spaces at flows of 2 litres/ minute.
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ADDENDUM
A recent article by Catterall, Kazantzis, and Hodges (1967) admits the presence of a dead space in the M.C. mask and estimates it to be approximately 90 ml.
